LIPA and metabolic dysfunction-associated steatotic liver disease: Since our primary focus was on testing if LAL overexpression could remedy NAFLD, we conducted RNA-Seq analysis on livers from the CON-GFP, FPC-GFP, and FPC-LIPA groups to validate the effects of the FPC diet and to determine the effects of LIPA within the NAFLD-promoting FPC diet in male mice.